Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Part D Brand And Generic Drug Price Increase Reviews Planned By HHS IG

This article was originally published in The Pink Sheet Daily

Executive Summary

Brand price increases will be compared to rate of inflation in study slated for FY 2017 completion; table provides overview of ongoing studies on Rx drugs covered by Medicare and Medicaid or regulated under 340B.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register